Companies: 10,639     total market cap: โ‚ฌ115.466 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Galmed Pharmaceuticals
GLMD
#10442
Rank
โ‚ฌ3.95 M
Marketcap
๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Country
0,72ย โ‚ฌ
Share price
-0.13%
Change (1 day)
-75.12%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2025 (TTM): -3,46ย โ‚ฌ

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -3,31ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -149,94ย โ‚ฌ an increase over its 2016 EPS that were of -227,97ย โ‚ฌ.

EPS history for Galmed Pharmaceuticals from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,46ย โ‚ฌ
2017-149,94ย โ‚ฌ-34.23%
2016-227,97ย โ‚ฌ56.84%
2015-145,35ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Catalent
CTLT
-5,38ย โ‚ฌ 62.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-0,91ย โ‚ฌ-72.49%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-0,64ย โ‚ฌ-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Evoke Pharma
EVOK
-2,14ย โ‚ฌ-35.22%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com